The Medical Briefing
Home
About
Search
Sign in
Subscribe
EN
EN

Français (FR)

English (EN)

Deutsch (DE)

Español (ES)

Português (PT)

Italiano (IT)

Русский (RU)

Ελληνικά (GR)

Logo

Français

English

Deutsch

Español

Português

Italiano

Русский

Ελληνικά

English

Key nephrology papers, summarized and commented on by a nephrologist, with a visual abstract for every study.

English

+1

Povetacicept in IgA nephropathy, subphenotypes of septic AKI, calciphylaxis and vitamin K, complicated urinary tract infections

Nov 16, 2026

•

5 min read

Povetacicept in IgA nephropathy, subphenotypes of septic AKI, calciphylaxis and vitamin K, complicated urinary tract infections

November 2026 edition (2/4)

English

+1

Felzartamab in IgA nephropathy, SGLT2 inhibitors and GLP-1RA in kidney transplant recipients, ACHIEVE, GLP-1RA and kidney health
LockSimple

Nov 13, 2026

•

4 min read

Felzartamab in IgA nephropathy, SGLT2 inhibitors and GLP-1RA in kidney transplant recipients, ACHIEVE, GLP-1RA and kidney health

Retrospective no. 12/12

English

+1

Calcitriol in IgA nephropathy, “universal” kidney, CONFIDENCE, FIDELITY
LockSimple

Nov 13, 2026

•

5 min read

Calcitriol in IgA nephropathy, “universal” kidney, CONFIDENCE, FIDELITY

Retrospective no. 11/12

English

+1

Lipoic acid, mercury and NELL1 membranous nephropathy, glyoxylic acid hair straightening, tolvaptan and dapagliflozin in polycystic kidney disease
LockSimple

Nov 13, 2026

•

5 min read

Lipoic acid, mercury and NELL1 membranous nephropathy, glyoxylic acid hair straightening, tolvaptan and dapagliflozin in polycystic kidney disease

Retrospective no. 10/12

English

+1

Rituximab and urinary loss, infliximab in interstitial nephritis, low-protein diet, anti-cMET in polycystic kidney disease
LockSimple

Nov 13, 2026

•

5 min read

Rituximab and urinary loss, infliximab in interstitial nephritis, low-protein diet, anti-cMET in polycystic kidney disease

Retrospective no. 9/12

English

+1

Iptacopan in IgA nephropathy, LIBERATE-D, finerenone versus spironolactone, omega-3 in hemodialysis (PISCES)
LockSimple

Nov 13, 2026

•

5 min read

Iptacopan in IgA nephropathy, LIBERATE-D, finerenone versus spironolactone, omega-3 in hemodialysis (PISCES)

Retrospective no. 8/12

English

+1

Telitacicept in IgA nephropathy, sodium and blood pressure, SGLT2 inhibitors (SMART-C), creatinine and cystatin C
LockSimple

Nov 13, 2026

•

5 min read

Telitacicept in IgA nephropathy, sodium and blood pressure, SGLT2 inhibitors (SMART-C), creatinine and cystatin C

Retrospective no. 7/12

English

+1

Atrasentan in IgA nephropathy, predictive antihypertensive prescribing, finerenone in type 1 diabetes, metformin and polycystic kidney disease
LockSimple

Nov 13, 2026

•

4 min read

Atrasentan in IgA nephropathy, predictive antihypertensive prescribing, finerenone in type 1 diabetes, metformin and polycystic kidney disease

Retrospective no. 6/12

English

+1

Ravulizumab in IgA nephropathy, dual diuretic therapy, fish oil in hemodialysis, CAR-T and fibrosis
LockSimple

Nov 13, 2026

•

6 min read

Ravulizumab in IgA nephropathy, dual diuretic therapy, fish oil in hemodialysis, CAR-T and fibrosis

Retrospective no. 5/12

English

+1

Sibeprenlimab in IgA nephropathy, CAR-T and AKI, anticoagulation in advanced CKD, FIND-CKD
LockSimple

Nov 13, 2026

•

4 min read

Sibeprenlimab in IgA nephropathy, CAR-T and AKI, anticoagulation in advanced CKD, FIND-CKD

Retrospective no. 4/12

English

+1

Enteric-coated budesonide and sparsentan in IgA nephropathy, SIADH, kidney replacement in cardiogenic shock
LockSimple

Nov 13, 2026

•

5 min read

Enteric-coated budesonide and sparsentan in IgA nephropathy, SIADH, kidney replacement in cardiogenic shock

Retrospective no. 3/12

English

+1

Tonsillectomy in IgA nephropathy, OPTI-MRC, dapagliflozin in dialysis, kidney biopsy on antiplatelet therapy
LockSimple

Nov 13, 2026

•

5 min read

Tonsillectomy in IgA nephropathy, OPTI-MRC, dapagliflozin in dialysis, kidney biopsy on antiplatelet therapy

Retrospective no. 2/12

English

+1

Anti-rituximab antibodies, dapagliflozin after cardiac surgery, protein intake and GFR, SIAD: urea or tolvaptan
LockSimple

Nov 13, 2026

•

6 min read

Anti-rituximab antibodies, dapagliflozin after cardiac surgery, protein intake and GFR, SIAD: urea or tolvaptan

Retrospective no. 1/12

Recommandations

+2

Anemia in chronic kidney disease: 2026 KDIGO guidelines
LockSimple

Nov 13, 2026

•

2 min read

Anemia in chronic kidney disease: 2026 KDIGO guidelines

First update since 2012: iron, ESAs, HIF-PHIs and transfusion

Recommandations

+2

Chronic kidney disease, classification and risk: 2024 KDIGO guidelines
LockSimple

Nov 13, 2026

•

1 min read

Chronic kidney disease, classification and risk: 2024 KDIGO guidelines

Estimating GFR, classifying CKD and predicting the risk of kidney failure

Recommandations

+2

Acute kidney injury: 2026 KDIGO guidelines
LockSimple

Nov 13, 2026

•

2 min read

Acute kidney injury: 2026 KDIGO guidelines

Draft presented at WCN 2026: predict, investigate, treat

Recommandations

+2

Acute kidney disease (AKD) and follow-up after AKI: 2026 KDIGO guidelines
LockSimple

Nov 13, 2026

•

2 min read

Acute kidney disease (AKD) and follow-up after AKI: 2026 KDIGO guidelines

Draft presented at WCN 2026: towards continuum nephrology

Recommandations

+2

Diabetes and chronic kidney disease: 2026 KDIGO guidelines
LockSimple

Nov 13, 2026

•

2 min read

Diabetes and chronic kidney disease: 2026 KDIGO guidelines

Draft guideline: an early cardio-renal strategy

Recommandations

+2

IgA nephropathy and IgA vasculitis: 2025 KDIGO guidelines
LockSimple

Nov 13, 2026

•

1 min read

IgA nephropathy and IgA vasculitis: 2025 KDIGO guidelines

Proteinuria targets, immunological control and kidney protection

Recommandations

+2

Autosomal dominant polycystic kidney disease: 2025 KDIGO guidelines
LockSimple

Nov 13, 2026

•

2 min read

Autosomal dominant polycystic kidney disease: 2025 KDIGO guidelines

Diagnosis, imaging-based prognosis, tolvaptan and extrarenal manifestations

Recommandations

+2

High blood pressure: 2025 ACC/AHA guidelines
LockSimple

Nov 13, 2026

•

1 min read

High blood pressure: 2025 ACC/AHA guidelines

Unchanged definition, < 130/80 mmHg target reaffirmed, including in CKD

Recommandations

+2

Kidney stones: 2026 CARI guidelines
LockSimple

Nov 13, 2026

•

1 min read

Kidney stones: 2026 CARI guidelines

Preventing recurrence: urine volume, salt, normal calcium and targeted treatments

Recommandations

+2

Chronic kidney disease and food additives (potassium, phosphorus): 2025 ASN guidance
LockSimple

Nov 13, 2026

•

2 min read

Chronic kidney disease and food additives (potassium, phosphorus): 2025 ASN guidance

Hidden, highly bioavailable sources of potassium and phosphorus

Recommandations

+2

Alport syndrome: 2025 French national protocol (PNDS, ORKiD network)
LockSimple

Nov 13, 2026

•

1 min read

Alport syndrome: 2025 French national protocol (PNDS, ORKiD network)

New national diagnosis and care protocol, August 2025

Recommandations

+2

Kidney disease of undetermined cause in adults: 2026 French national protocol (PNDS, ORKiD network)
LockSimple

Nov 13, 2026

•

1 min read

Kidney disease of undetermined cause in adults: 2026 French national protocol (PNDS, ORKiD network)

Think genetic diagnosis

Recevoir la newsletter · Get the newsletter

Explore

Home

Archive

About

Contact

Follow us on LinkedIn

Subscribe

Free subscription

Premium subscription

Mentions légales

CGU

© 2026 The Medical Briefing - Nephrology.
beehiivPowered by beehiiv